At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
SQZ SQZ Biotechnologies Company
Delisted 11-15 16:00:00 EST
0.4350
+0.0000
0.00%
High0.4350
Low0.4350
Vol0.00
Open0.4350
D1 Closing0.4350
Amplitude0.00%
Mkt Cap12.83M
Tradable Cap9.35M
Total Shares29.49M
T/O0.00
T/O Rate0.00%
Tradable Shares21.49M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
SQZ Biotechnologies to effect 1-for-10 reverse stock split
Analysts Have Conflicting Sentiments on These Healthcare Companies: Avadel Pharmaceuticals (AVDL), scPharmaceuticals (SCPH) and SQZ Biotechnologies (SQZ)
BRIEF-Sqz Biotechnologies Announces Confirmed Complete Response In Hpv16+ Solid Tumor Patient In The Lowest-Dose Cohort Of The Sqz-Aac-Hpv-101 Clinical Trial
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. The Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.